Recommendation update and new therapeutic approach

Allergic rhinitis (AR) is still often trivialized, but there is no reason for this: It is a major chronic respiratory disease with high prevalence and impact on quality of life, and it is also considered a risk factor for asthma. A new study shows how the disease can affect performance. In allergen-specific immunotherapy, there are new approaches using monoclonal IgG antibodies. An expert provided insight into studies and therapy developments.